AI CuratorAI-generated
Research summary · AI summary · not yet reviewedSubjects not reportedNot reportedTrial registry
COVID-19 Impact on MS Study with 30 Participants
A study with a planned enrollment of 30 participants was terminated due to patients declining to come to the hospital for continued participation amid COVID-19. Consequently, results were not reported.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
This highlights the significant impact of the COVID-19 pandemic on clinical research, particularly in vulnerable populations like those with MS, which may affect the timely understanding of treatment efficacy and safety.
What this does not prove
No results are available, and the planned enrollment and endpoints do not constitute findings; thus, no conclusions can be drawn from this study.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- 30 · basis not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- No
- Research areas
- Not classified
Original sources
- Trial registrationValidation of the BeCare Multiple Sclerosis Assessment App ↗
Supporting passages (4)
sample size"enrollmentInfo": { "count": 30, "type": "ACTUAL" }
regulatory approval"isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false
findingsPatients did not want to come to hospital for continued participation",
limitationsPlanned enrolment and endpoints are not findings.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.